New Zila Tolonium Chloride Patent Issued

Zila has been granted an additional U.S. patent for its Zila Tolonium Chloride product.

The patent was issued recently for In Vivo Stain Compounds and Methods of Use to Identify Dysplastic Tissue, and covers certain compounds within the Zila Tolonium Chloride product and the use of these compounds in detecting dysplastic tissue. Dysplastic tissue has been shown in the scientific literature to be a potential precursor to cancer.